BioMarin Pharmaceuticals Inc (BMRN): Today's Featured Health Care Laggard

BioMarin Pharmaceuticals ( BMRN) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.1%. By the end of trading, BioMarin Pharmaceuticals fell 40 cents (-1.1%) to $37.61 on light volume. Throughout the day, 638,548 shares of BioMarin Pharmaceuticals exchanged hands as compared to its average daily volume of 1.7 million shares. The stock ranged in price between $37.29-$37.92 after having opened the day at $37.80 as compared to the previous trading day's close of $38.01. Other companies within the Health Care sector that declined today were: Codexis ( CDXS), down 21.3%, Heska Corporation ( HSKA), down 15.8%, Sunshine Heart ( SSH), down 15.5%, and Senesco Technologies ( SNT), down 13.3%.

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and rest of the world. BioMarin Pharmaceuticals has a market cap of $4.72 billion and is part of the drugs industry. Shares are up 11.2% year to date as of the close of trading on Thursday. Currently there are 13 analysts that rate BioMarin Pharmaceuticals a buy, no analysts rate it a sell, and three rate it a hold.

TheStreet Ratings rates BioMarin Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity.

On the positive front, Kips Bay Medical ( KIPS), up 16.1%, Tengion ( TNGN), up 15.2%, Metropolitan Health Networks ( MDF), up 12.8%, and AspenBio Pharma ( APPY), up 12.8%, were all gainers within the health care sector with Warner Chilcott ( WCRX) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

5 Top Stocks With 100% Buy Ratings Right Now

5 Top Stocks With 100% Buy Ratings Right Now

Why I Stay Very Focused on My Individual Stocks

Why I Stay Very Focused on My Individual Stocks

7 Winners and Losers From Biggest Biotech Conference of 2017

7 Winners and Losers From Biggest Biotech Conference of 2017

Bluebird Bio Becoming Household Name With This Promising Cancer Treatment

Bluebird Bio Becoming Household Name With This Promising Cancer Treatment